A new study shows that the taking of diabetes medicine reduces the risk of getting Parkinson´s disease.

Researchers have discovered that medical treatment against diabetes reduces the risk of getting Parkinson´s disease by 35 percent.

The researchers believe that diabetes medicines, containing glitazones, are influencing the cells to produce more mitochondria. Mitochondria are the powerhouse of the cells, transforming nutrients that the cells need to work.

The research group has previously shown that the production of mitochondria decreases during Parkinson´s.

To see the connection between diabetes and Parkinson´s, the researchers analysed and compared data from the Norwegian Prescription Data Base. The database has stored information on all use of prescription the last 10 years and contains data on more than 100 million prescriptions.

Paper: “Glitazone use associated with reduced risk of Parkinson’s disease”

Reprinted from materials provided by University of Bergen.

февруари 2, 2018